DrugPatentWatch Database Preview
Profile for World Intellectual Property Organization (WIPO) Patent: 0235440
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 0235440
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 23, 2020 | Celgene | POMALYST | pomalidomide |
➤ Try a Free Trial | Oct 23, 2020 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | Oct 23, 2020 | Celgene | THALOMID | thalidomide |
➤ Try a Free Trial | Oct 23, 2020 | Celgene | POMALYST | pomalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |